Segovia C, San Jose Eneriz E, Munera Maravilla E, Martínez Fernández M, Garate L, Miranda E, et al. Inhibition of a G9a/DNMT network triggers immune-mediated bladder cancer regression. Nat Med. 2019;25:1073-1081 pubmed publisher

Gerez J, Prymaczok N, Rockenstein E, Herrmann U, Schwarz P, Adame A, et al. A cullin-RING ubiquitin ligase targets exogenous α-synuclein and inhibits Lewy body-like pathology. Sci Transl Med. 2019;11: pubmed publisher

Flores Cuadrado A, Saiz Sanchez D, Mohedano Moriano A, Martinez Marcos A, Ubeda Bañon I. Neurodegeneration and contralateral α-synuclein induction after intracerebral α-synuclein injections in the anterior olfactory nucleus of a Parkinson's disease A53T mouse model. Acta Neuropathol Commun. 2019;7:56 pubmed publisher

Joniec Maciejak I, Ciesielska A, Poniatowski Ł, Wawer A, Sznejder Pachołek A, Wojnar E, et al. Effects of α-Synuclein Monomers Administration in the Gigantocellular Reticular Nucleus on Neurotransmission in Mouse Model. Neurochem Res. 2019;44:968-977 pubmed publisher

Rodriguez Araujo G, Nakagami H, Takami Y, Katsuya T, Akasaka H, Saitoh S, et al. Low alpha-synuclein levels in the blood are associated with insulin resistance. Sci Rep. 2015;5:12081 pubmed publisher

Koehler N, Stransky E, Meyer M, Gaertner S, Shing M, Schnaidt M, et al. Alpha-synuclein levels in blood plasma decline with healthy aging. PLoS ONE. 2015;10:e0123444 pubmed publisher

Roberts R, Wade Martins R, Alegre Abarrategui J. Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain. Brain. 2015;138:1642-57 pubmed publisher

Lee B, Kamitani T. Improved immunodetection of endogenous α-synuclein. PLoS ONE. 2011;6:e23939 pubmed publisher

Sidhu A, Wersinger C, Vernier P. alpha-Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease. FEBS Lett. 2004;565:1-5 pubmed

Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, et al. Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science. 2000;287:1265-9 pubmed